BackFit Health + Spine has accumulated 288 reviews on its Google Business Profile for the Desert Ridge location in Phoenix, achieving an aggregate rating of 4.9 stars. This accumulation of patient ...

BackFit Health + Spine has accumulated 335 reviews on its Google Business Profile for the Goodyear location, achieving an ...

Sanofi has secured regulatory approval in China for two innovative medicines, Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome. The approvals ...

HCM City (VNA) - More than seven years after its launch, Ho Chi Minh City’s One Commune, One Product (OCOP) programme is ...

Briony takes a look at the latest tt eSports Nemesis Switch mouse which retails for $50 in the us - that's a pretty good price, but you can imagine our surprise when it was selling for £60 in the uk - ...

Myqorzo and Redemplo approved in ChinaApproval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia ...

Myqorzo and Redemplo approved in China Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndromeUnderscores Sanofi's long-term commitment to ...

First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment - ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical programs and highlighted major milestones for 2026.

SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027$10 million milestone payment triggered from licensing agreement ...

Assam Chief Secretary Ravi Kota on Saturday held a review meeting to assess preparedness for Prime Minister Narendra Modi’s ...

Clara accelerates sanctions adjudication with AI-driven decisions, explainable reasoning, and fully traceable audit ...